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Abstract  
Common Ragweed is a highly allergenic invasive species in Europe, expected to become widespread 
under climate change.  Allergy to ragweed manifests as eye, nasal and lung symptoms, and children 
may retain these throughout life.  The dose-response relationship between symptoms and pollen 
concentrations is unclear.  We undertook a longitudinal study, assessing the association between 
ragweed pollen concentration and allergic eye, nasal and lung symptoms in children living under a 
range of ragweed pollen concentrations in Croatia.  Over three years, 85 children completed daily 
diaries, detailing allergic symptoms alongside daily location, activities and medication, resulting in 
10,130 individual daily entries.  The daily ragweed pollen concentration for the children's locations 
was obtained, alongside daily weather and air pollution.  Parents completed a 
home/lifestyle/medical questionnaire.  Generalised Additive Mixed Models established the 
relationship between pollen concentrations and symptoms, alongside other covariates.  Eye 
symptoms were associated with mean daily pollen concentration over four days (day of symptoms 
plus 3 previous days); 61 grains/m3/day (95%CI:45,100) was the threshold at which 50% of children 
reported symptoms.  Nasal symptoms were associated with mean daily pollen concentration over 12 
days (day of symptoms plus 11 previous days); the threshold for 50% of children reporting symptoms 
was 40 grains/m3/day (95%CI:24,87).  Lung symptoms showed a relationship with mean daily pollen 
concentration over 19 days (day of symptoms plus 18 previous days), with a threshold of 71 
grains/m3/day (95%CI:59,88).  Taking medication on the day of symptoms showed higher odds, 
suggesting responsive behaviour.  Taking medication on the day prior to symptoms showed lower 
odds of reporting, indicating preventative behaviour.  Different symptoms in children demonstrate 
varying dose-response relationships with ragweed pollen concentrations.  Each symptom type 
responded to pollen exposure over different time periods.  Using medication prior to symptoms can 
reduce symptom presence.  These findings can be used to better manage paediatric ragweed allergy 
symptoms.     
 
Highlights 
 The dose-response between ragweed concentrations and allergy symptoms is unclear 
 We used a longitudinal study to determine daily allergy symptoms in 85 children 
 Associations between daily symptoms and ragweed concentrations were examined 
 Generalised Additive Mixed Models (GAMM) were used for analysis  
 Symptom types showed different non-linear associations with ragweed concentration 
 Symptom types responded to pollen exposure over differing time periods 
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1. Introduction 
Ambrosia artemisiifolia (hereafter ragweed) is a herbaceous plant native to North America.  In 
Europe, ragweed is an introduced species (Smith et al., 2013) in the process of an ongoing invasion 
event (Storkey et al., 2014).  Each ragweed plant produces over one billion pollen grains (Fumanal et 
al., 2007) which are highly allergenic (Smith et al., 2013).  The concentration of ragweed pollen in 
the atmosphere varies considerably across Europe, from a total absence up to an annual count of 
over 25000 pollen grains/m3/year (Matyasovszky et al., 2018).  The ragweed sensitisation rate (the 
proportion of people developing an allergic reaction to a substance via a skin prick test) is above 2% 
in all European countries (Burbach et al., 2009), with rates varying from 50-60% in Hungary (Burbach 
et al., 2009), to 14-20% in Germany (Ruëff et al., 2012) and less than 3% in France, Spain, Italy, 
Sweden and the UK (Bousquet et al., 2007).   
Allergy to ragweed predominantly manifests clinically as allergic rhino-conjunctivitis and allergic 
asthma (Bass et al., 2000; Salo et al., 2014).  The symptoms occur in late summer/autumn and 
include nasal congestion, ocular redness, itching of the nose or eyes, sneezing, runny nose, coughing, 
wheezing and dyspnoea.  Rhino-conjunctivitis and asthma are commonly co-morbid (Leynaert et al., 
2000).  The burden of ragweed allergy goes beyond physical symptoms however, with impacts on 
sleep quality (Meltzer et al., 2009; Nathan, 2007), school attendance (Nathan, 2007; Kay, 2000; 
Sennhauser et al., 2005), lost workdays (Nathan, 2007) and emotional and social health (Nathan, 
2007; Meltzer et al., 2009; Sennhauser et al., 2005), all of which have negative effects on overall 
quality of life and economic well-being (Meltzer et al., 2009; Sennhauser et al., 2005; Nathan, 2007).  
Zuberbier et al. (2014) have calculated that the economic burden of allergic disease in the EU is 
between €55 and €151 billion per annum.   
Climate change is likely to impact on ragweed allergy in Europe.  Under climate change it is expected 
that the distribution of ragweed in Europe will expand to areas where it is currently not found 
(Storkey et al., 2014).  By 2060, it is predicted that the quantity of ragweed pollen that the 
population will be exposed to will substantially increase, and the pollen season will lengthen (Lake et 
al., 2017).  Alongside this, by 2060 the rate of sensitisation to ragweed is predicted to more than 
double across Europe, with rates increasing both in areas where ragweed is currently prevalent and 
where it is presently uncommon (Lake et al., 2017).  Thus, as a result of the increase in pollen 
concentrations, ragweed pollen allergy will become an increasingly common health problem across 
Europe (Lake et al., 2017). 
Despite this large and growing health problem, very few studies have investigated the associations 
between ragweed pollen levels and allergy symptoms, and the effect of pollen exposure on 
childhood rhino-conjunctivitis is largely unknown (Cakmak et al., 2002).   In Italy, Albertini et al. 
(2012) described a correlation between the number of (mainly adult) patients with asthmatic 
symptoms and the total annual ragweed pollen concentration.  In the USA, 24 asthma patients aged 
9-64 completed a symptom diary over a two month period, and correlated asthma and rhinitis 
symptoms with environmental factors.  The study found a positive correlation between symptoms 
and ragweed pollen levels (Newhouse and Levetin, 2004).  Studies in Canada have shown an 
association between ragweed concentration and physician visits for rhinitis in the elderly (Villeneuve 
et al., 2006) and patients of all ages (Breton et al., 2006).  In France, a country where the average 
total annual ragweed pollen count varies geographically from 4 pollen grains/m3/year to 5374 pollen 
grains/m3/year (Thibaudon et al., 2014), a more extensive longitudinal study using daily diaries over 
two years found a significant positive linear relationship between ragweed exposure and daily hay 
fever symptoms in 30 adults sensitised to ragweed (Caillaud et al., 2014).  Despite both laboratory 
(Naclerio et al., 1983; Solomon, 1984) and clinical (Comtois and Gagnon, 1988; Peternel et al., 2008) 
studies, no precise ragweed pollen threshold for triggering allergy symptoms has been established 
(Peternel et al., 2008).  To our knowledge there are no longitudinal studies examining the dose-
response relationship between ragweed pollen levels and paediatric allergic symptoms, focused on 
areas with a range of ragweed pollen concentrations including very high levels.   
The aim of this study is to examine how daily ragweed pollen levels influence a range of allergy 
symptoms in a cohort of ragweed-sensitised children in Croatia.  Croatia is considered one of the 
most ragweed affected countries in Europe (Rybníček and Jäger, 2001; Peternel et al., 2005; Galzina 
et al., 2010) with annual pollen counts measuring up to 24801 pollen grains/m3/year (Peternel et al., 
2005) in the most highly infested areas.  Given the predicted increase in pollen concentrations across 
Europe (Lake et al., 2017), it is important to investigate the associations between pollen 
concentrations and symptoms in areas which already have high pollen concentrations.  Children are 
useful to study as their epidemiological history is less complex than adults, and children who develop 
symptoms early are likely to retain them later in life (Rhodes et al., 2002; Illi et al., 2006).  To our 
knowledge, this is the first longitudinal study to examine the dose-response relationship between a 
range of daily allergy symptoms and ragweed pollen in European children.    
  
2. Methods 
The purpose of this study is to use an epidemiological study design to explore the relationship 
between observed levels of pollen in the environment and reported symptoms in children, 
controlling for a range of confounding variables.  
 
2.1 Study design 
Between April 2012 and June 2014, 4015 children were recruited through schools and kindergartens 
from three areas of Croatia representing a range of ragweed levels: Dalmatia (low pollen: average 
total annual pollen 422 grains/m3/year), Zagreb (medium pollen: average total annual pollen 5189 
grains/m3/year) and Slavonia (high pollen: average total annual pollen 13079 grains/m3/year).  
Children with chronic immunosuppressant or antihistamine therapy were excluded from 
participating as these interfere with skin prick tests.  Using standard allergy skin prick tests (allergen 
extract Alyostal ST-IR, Stallegenes S.A. France), children were tested for sensitisation to a palette of 
aeroallergens including ragweed.  From these recruits, 85 children who were sensitised to Ambrosia 
(defined as a wheal size >2 mm) volunteered to complete a daily symptom diary, developed from a 
standardised allergy symptom and medication use questionnaire (see www.pollendiary.com; 
Voukantsis et al. (2015)).  Altogether 55% of the children were also sensitised to cross-reactive 
pollens (birch, hazel, pine, olive, grass, and Parietaria pollen).  The children (or their parents) 
recorded their daily symptoms and activity over the pollen season (22nd July to 31st October) for the 
years 2012 (29 children), 2013 (49 children) and 2014 (24 children).  Sixteen children completed 
diaries on multiple years.  Further details of the recruitment and diagnostic tests are detailed 
elsewhere (Agnew et al., 2018). 
2.2 Daily diary, pollen, environment and lifestyle data  
The symptom diaries included details of the children's daily allergy symptoms.  Eye symptoms 
(itching, redness, foreign body sensation and watering), nasal symptoms (itching, sneezing, running 
and blocked nose) and lung symptoms (wheezing, shortness of breath, cough and asthma) were 
recorded.  An overall score for each set of symptoms was produced, indicating the "presence" of any 
symptom or the "absence" of any symptoms.  Altogether three dichotomous symptom measures 
were generated: reported any eye symptoms (yes/no), reported any nasal symptoms (yes/no) and 
reported any lung symptoms (yes/no).  The daily geographical locations of the children were 
detailed, indicating whether they were at home or at another location (e.g. on holiday) and where 
they were located on a two hourly basis each day (home, school, outside).  The activities they were 
participating in on a two hourly basis were also recorded (including sleeping, resting/learning, sport).  
Any medication the child had taken was noted.   
Using Geographical Information Systems (GIS) (ArcGIS 10.2), each child was assigned to their nearest 
pollen observation site (Croatian Environment Agency).  Daily measures of ragweed pollen 
(grains/m3) were obtained for the child’s location (either home or away) giving each child an 
individual pollen grain measure for each diary day, based on their location.  Figure 1 presents raw 
data showing the crude relationships between total daily pollen grains/m3 (in percentiles) and the 
percentage of days when children reported symptoms.  For all three symptoms the percentage of 
days when children reported symptoms increases with pollen grains/m3 that day. 
Children were allocated to their nearest weather and air quality stations, from where potential 
confounding variables including daily temperature, rainfall and air quality data (mean concentration 
of SO2, PM10, NO2, O3) for their daily location was obtained.  In addition, a parental questionnaire 
collected information on the home environment, lifestyle, family/personal medical history and socio-
economic information (ISAAC Phase II questionnaire – see   
http://isaac.auckland.ac.nz/phases/phasetwo/phasetwo.html; Asher et al. (1995)).  Also using GIS, 
information on the home environment was determined, such as whether the home was in a rural or 
urban area, based on CORINE Land cover data (European Environment Agency (2015); see Agnew et 
al. (2018) for more details).  The study protocol and informed consent, based on the international 
Declaration of Helsinki, Declaration on Human Rights and local legislation, were approved by the 
Local Ethics Committee (Children‘s Hospital Srebrnjak, Croatia) and the E.U. ATOPICA project Ethics 
Committee.  
2.3 Statistical analysis  
Generalised Additive Mixed Models, GAMM (Wood, 2006) with a binomial specification were used 
to evaluate the potential non-linear and delayed associations between the exposure to ragweed 
pollen and the presence of symptoms. GAMMs are semi-parametric extensions of generalised linear 
models where the linear predictor is replaced by a sum of smooth functions (Hastie and Tibshirani, 
1986). One advantage of GAMMs is that they automatically estimate the optimal degree of non-
linearity of a model directly from the data (Wood, 2006). Separate models were run for reported 
eye, nasal and lung symptoms.  All analyses were undertaken in R version 3.4.4 (R Core Team 2018). 
When investigating the impact of pollen on allergic symptoms it is common to consider pollen over 
the consecutive days prior to symptoms, as in epidemiological studies lagged relationships are often 
found (Breton et al., 2006; Villeneuve et al., 2006; Erbas et al., 2018).  It is also suggested that the 
clinical response to pollen tends to increase as the pollen season develops (Tobias et al., 2004), the 
sustained effect of environmental stimuli potentially have cumulative long-lasting effects (Frey and 
Suki, 2008) and that elevated concentrations of pollen from previous days can have an additive 
effect, resulting in heightened allergy symptoms (Newhouse and Levetin, 2004).  Therefore, to 
account for lagged and cumulative effects of pollen on symptoms, the influence of pollen on the 
days previous to the symptom day were examined.  Individual associations between symptoms on a 
day and the pollen concentration on the days previous to the symptoms were examined (see 
Supplementary Table S1).  The continuous days where the individual association between daily 
pollen concentration and symptoms was p<0.01 were used to compute a mean daily pollen 
concentration measure.  The number of days where pollen had an influence varied for the different 
symptoms.  Four days (day of symptoms plus the three previous days) for eye symptoms (Pollen03), 
12 days (day of symptoms plus the 11 previous days) for nasal symptoms (Pollen011) and 19 days 
(day of symptoms plus the 18 previous days) for lung symptoms (Pollen018).  The mean pollen 
concentrations over these time periods were included in the model as the main pollen measure.  
Zheng et al. (2015) suggest that lags are essential in time-series studies to better determine the 
effects of outdoor air pollution on asthma outcomes and thus we used matching time lags to 
account for any potential effect of SO2, PM10, NO2, and O3 on the presence of symptoms. 
In the development of the models, all variables shown in Agnew et al. (2018) to be associated with 
ragweed sensitised children and the development of allergic disease were included as potential 
explanatory variables, alongside additional time series measures (day, year and measure of early or 
late season, child locations, daily symptoms, daily medication, daily activity, weather, air pollutants).  
A core model was developed including the unique identifier of each child, the unique identifier for 
each area, mean daily pollen concentration, mean daily temperature (oC), total daily rainfall 
(mm/day), gender, age group and year.  Also included was the logarithm of the binary symptom 
scores lagged one day to account for potential temporal correlation in the data (Imai et al., 2015).  
Any other variables adding to the explanatory power of the model were retained.  A full list of 
potential explanatory variables is shown in Supplementary Table S2.  The general algebraic definition 
of the core model is given by: 
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where p denotes the probability of the symptoms occurring and 0 < p < 1; α is the intercept; ID 
indicates the child specific random effects; Area is the area-specific random effects;  ln(St-1) is the 
natural logarithm of the symptoms on the previous day; Year is a categorical variable for each year in 
the records; Age corresponds to the age group of the child; Sex indicates the gender of the child; β is 
the coefficient of each weather variable (X) in the model; and s denotes the smooth function of 
pollen (Z) lagged zero to L days.  
For each predictor not present in the core model, we iteratively incorporated the predictor leading 
to the lowest Akaike’s information criterion (AIC) until no further variable incorporations lowered 
the AIC.  Supplementary Table S3 shows the change in AIC for each additional variable.  Model 
selection was conducted using the AIC because it performs better than hypothesis-based approaches 
(Mazerolle, 2006). Notably, the AIC as a value is meaningless by itself and is meaningful only when 
compared with other AIC values from other models.  The model with the lowest AIC is considered 
the most adequate model (Symonds and Moussalli, 2011). Within the models, some non-significant 
variables have been retained when they improve the fit of the model.  There were no patterns in the 
residual plots, confirming these as the most appropriate models.     
 
3. Results 
Altogether, 85 children completed diaries over 306 days that covered three ragweed pollen seasons, 
resulting in 10,130 individual daily diary entries.  In total, 38% of the children were girls, their ages 
ranged from 4 to 12 and 63% lived in the Zagreb area, whilst 29% lived in Slavonia and 7% in 
Dalmatia.  Of the 85 children, 56 (66%) reported eye symptoms, 75 (88%) reported nasal symptoms 
and 41 (48%) reported lung symptoms.  Table 1 summarises the main characteristics of the children 
in the study.   
In the eye model, mean daily pollen concentrations were based on four days (day of symptoms plus 
previous three days - Pollen03).  The dose-response relationship between the mean daily pollen 
concentration (Pollen03) and the probability of reported eye symptoms is shown in Figure 2.  The X 
axis represents increasing levels of pollen (expressed in grains/m3/day).  The rug (lines) at the 
bottom indicates the density of observations at each level of pollen.  The majority of children were 
exposed to a mean daily pollen concentration (Pollen03) of less than 500 grains/m3.  The Y axis 
shows the probability of reported eye symptoms.  The smooth line indicates the maximum likelihood 
estimates for the risk of symptoms, and the dashed lines represent the 95% confidence intervals.  
The relationship between pollen and the risk of symptoms was non-linear.  There was an increase in 
the probability of symptoms up to around 500 grains/m3/day after which the relationship flattens; 
however, the large confidence intervals at pollen levels above 500 grains/m3/day suggest large 
uncertainties in the association between reported eye symptoms and pollen at high pollen levels.  
These large confidence intervals were the result of low numbers of children being exposed to these 
levels of pollen.  The dotted lines indicate the threshold of pollen where 50% of children reported 
symptoms.  For eye symptoms it was 61 grains/m3/day (95% confidence intervals: 45, 100). 
Table 2 contains the model for the reported presence or absence of eye symptoms.  Predictors 
which showed significantly lower odds of reported eye symptoms included being ten years or older, 
being away from home, taking nasal sprays or drops on the day before reported symptoms and 
increased time spent being active outside.  Conversely, reporting symptoms on the day previous, 
taking nasal sprays or drops on the day, the year 2013 and daily temperature showed significantly 
higher odds of reported eye symptoms.   
In the nasal model, mean daily pollen concentrations were based on 12 days of pollen (day of 
symptoms plus previous 11 days - Pollen011).  Figure 3 shows the dose-response relationship 
between mean daily pollen concentration (Pollen011) and the probability of reported presence of 
nasal symptoms.  As can be seen from the rug, most children were exposed to a mean daily pollen 
concentration (Pollen011) of less than 400 grains/m3.  There was a non-linear and positive 
relationship between the mean daily pollen concentration and the risk of reported nasal symptoms.  
The increase in the risk of reported nasal symptoms was steeper at levels between 0 and 100 
grains/m3/day after which the relationship gradually started to flatten.  For nasal symptoms the 
threshold for reported symptoms to appear in 50% of children was 40 grains/m3/day (95% 
confidence intervals: 24, 87).   
The model for the associations with the reported presence or absence of nasal symptoms is shown 
in Table 3.  Being away from home and the rainfall on the day of measurement showed lower odds.  
Reporting nasal symptoms on the previous day, taking nasal sprays or drops on the day, and mean 
daily temperature increased the odds of reported nasal symptoms.   
In the lung model, mean daily pollen concentration was based on 19 days of pollen (day of 
symptoms plus previous 18 days - Pollen018).  Figure 4 highlights the dose-response relationship 
between the probability of reported lung symptoms and the mean daily pollen concentration 
(Pollen018).  Most children were exposed to a mean daily pollen concentration below 350 
grains/m3/day.  There was a non-linear and positive relationship between pollen concentration and 
the risk of reported lung symptoms, with the relationship starting to flatten around 300 
grains/m3/day.  Approximately 71 grains/m3/day (95% confidence intervals: 59, 88) was the 
threshold which triggered the reported appearance of lung symptoms in 50% of children.   
Table 4 shows the model for reported lung symptoms.  Time spent being active and the year 2014 
showed significantly lower odds.  Higher odds of reported lung symptoms were significantly 
associated with reported lung symptoms on the previous day and taking asthma medication on the 
same day.   
 
4. Discussion 
When examining the relationship between ragweed pollen concentration and reported symptoms, 
lagged and cumulative effects were considered, as in previous studies (Breton et al., 2006; 
Villeneuve et al., 2006; Erbas et al., 2018).  The number of days when ragweed pollen was associated 
with symptoms varied for the different symptomologies.  For eye symptoms, only pollen levels on 
the day of symptoms plus the three previous days were relevant, suggesting that eye symptoms are 
an immediate response to ragweed pollen.  Nasal symptoms were an longer response, as the 
ragweed pollen concentration over the day of symptoms plus the 11 previous days were associated 
with nasal symptoms.  Meanwhile, the response of the lungs to ragweed pollen exposure was over 
the longest period, as the day of symptoms plus  the 18 previous days were associated with lung 
symptoms.  To our knowledge, no other studies have investigated the pollen lag structure for self-
reported symptoms in children.  Where the impact of ragweed pollen on symptoms has been 
examined, there is little consistency in the length of lags, with studies showing five (Breton et al., 
2006), ten (Villeneuve et al., 2006) and 15 (Newhouse and Levetin, 2004) days of pollen impacting on 
allergic rhinitis (Breton et al., 2006; Villeneuve et al., 2006), and asthma and allergic rhinitis 
(Newhouse and Levetin, 2004).  
There is a non-linear positive dose-response relationship between ragweed pollen concentration and 
reported eye, nasal and lung symptoms, although this relationship differs for the three types of 
reported symptoms.  Interestingly, Caillaud et al. (2014), who investigated both linear and non-linear 
relationships between hay fever symptoms in adults and ragweed pollen counts, observed a linear 
relationship, at a lower range of pollen levels (ranging from 0 – 543 grains/m3/day).   
For all reported symptoms, taking medication on the day of symptoms was associated with a 
significantly greater chance of symptoms occurring, as was found in the French study (Caillaud et al., 
2014).  It is unclear whether reported medication was taken for prevention or relief of symptoms, 
however our findings suggest that taking medication on the day is a response to symptoms, rather 
than preventative.  Our study also showed that taking medication on the previous day was 
significantly associated with a lower likelihood of reported eye symptoms.  In particular, taking nasal 
sprays or nose drops on the previous day was associated with a lower likelihood of reported eye 
symptoms.  The links between nasal and ocular symptoms remain unclear (Siroux et al., 2018), 
however, pathways of nasal-ocular communication are thought to increase the risk of inflammation 
at both sites following allergen exposure (Bielory, 2010) and nasal sprays are used as treatments for 
ocular symptoms associated with allergic rhinitis (Naclerio, 2008).  Thus, the association between 
the use of nasal sprays and eye symptoms is plausible.  Very few children in the study reported the 
use of eye drops and therefore these were not included in the models.  The use of anti-allergy 
tablets was retained in the lung model because it added explanatory power, although it was not 
significant.  Our findings indicate taking medication on the day before symptoms has a positive 
effect on reducing eye symptoms, thus it is interesting that, despite the recognised links between 
nasal medication and ocular symptoms (Naclerio, 2008), many children are not using these 
medications and are symptomatic for many days.  In this cohort, 15 children reported eye symptoms 
on at least one day and took no nasal sprays or nose drops, while 11 children reported eye 
symptoms for more than seven days and took no nasal sprays or nose drops.  As Croatia has a 
ragweed pollen forecast system in place (Peternel et al., 2005; Andrija Stampar Teaching Institute of 
Public Health, 2019) information is available to allow for the commencement of regular treatment in 
advance of the ragweed pollen season (Scadding, 2015) as a pragmatic approach to current and 
likely future increasing pollen levels and hence symptoms.  
There has long been a question over the impact of physical activity on allergy symptoms (Lucas and 
Platts-Mills, 2005).  Our study shows that being active outdoors is associated with a lower likelihood 
of reported eye symptoms, while being active either indoors or outdoors was associated with a 
lower probability of lung symptoms.  A Greek investigation has shown a trend towards a reduction in 
asthma symptoms amongst children who participate in physical activity outdoors (Kosti et al., 2012).  
However, it has been suggested that children with allergy symptoms are less likely to participate in 
exercise, sport or playing with friends (Meltzer et al., 2009) and thus those being active may be 
those who suffer fewer symptoms.  Further investigation into the relationship between allergy 
symptoms and both indoor and outdoor physical activity is required.  
Weather also influenced allergic symptoms, independently of the impact of weather on pollen.  
Higher daily temperature was associated with an increased likelihood of reported eye and nasal 
symptoms, which supports previous data (Medek et al., 2012).  Conversely, rainfall has a protective 
impact on reported nasal symptoms, which is similar to an Australian study which found that allergy 
symptoms decreased after rainfall events (Medek et al., 2012) but differs from a European study 
which found asthma and wheeze to be positively associated with rainfall (Arnedo-Pena et al., 2013).  
Further investigation is required to determine how temperature and rainfall drive allergic symptoms 
independently of pollen.            
The majority of our study participants who stated they were away from home had travelled from a 
higher pollen area to a lower pollen area.  Being away from home was protective for eye and nasal 
symptoms, but not for lung symptoms.  This effect is seen even controlling for changing pollen 
levels.  This suggests that there is a protective effect on eye and nasal symptoms of moving from an 
area with a high ragweed pollen load to an area with a lower load, which is not captured by our 
mean daily pollen concentrations (Pollen03, Pollen011).  The reasons for this are unclear.    
We considered whether the day of the week was important, as nasal symptoms have been shown to 
vary between week days and weekends in adults (Caillaud et al., 2014), but this measure was not 
significant and did not improve the fit of the model.  This may be because we were looking at 
children rather than adults and because much of the ragweed season occurs during the school 
holidays, when inter-day activities may be similar.   
Our study demonstrates that it is possible to collect extensive self-reported diary data on the allergy 
symptoms and behaviour of children aged 4 – 12 over a three-year period.  Previous studies indicate 
that the use of personal diaries to collect data on allergy symptoms is valid in adults (Jantunen et al., 
2012; Globe et al., 2015) and children (Casas et al., 2017).  However, there are limitations to our 
study.  As the symptoms measured were self-reported and not medically determined, it is not 
possible to assess their clinical importance.  However, any self-reported symptoms affecting daily 
activities might be considered important, and Bousquet et al. (2018) have shown that using a simple 
electronic self-report method can accurately assess nasal symptoms.  The children (or their parents) 
were self-selecting for the overall study and although those invited to participate in the diary 
element were chosen because of their ragweed sensitisation, they participated voluntarily.  This may 
result in a biased sample, but the analysis focus was differences in symptoms over time and not 
between children.  There was an uneven sampling distribution of participant age (62% aged 7-9), 
gender (62% male) and geographic location (64% in the Zagreb area).  Participant numbers also 
varied across ragweed seasons, with almost twice as many in 2013 (49) than in 2012 (29) and 2014 
(24).  However, all these factors were controlled for in the analysis.   
Measurements from pollen observation stations may not reflect the levels of pollen to which 
children are exposed.  In this study, children were selected if their school was within 15 km of a 
ragweed pollen station (Agnew et al., 2018).  However, pollen levels will vary within this zone, and 
additionally, the location of the child's home and daily activities may be outside this zone.  Wherever 
possible if the child was away from home (e.g. on holiday), values from the nearest pollen station to 
their known location were used, but this may have been greater than 15 km.  Therefore, the actual 
pollen level the child was exposed to may differ from the measured amount.  The same limitations 
hold for the weather and air quality data, where observation networks are sparser.   
To our knowledge, this is the first study to examine reported daily allergy symptoms and ragweed 
pollen in European children living under a range of pollen concentrations, including areas with very 
high ragweed pollen concentrations.  We have examined the influence of daily ragweed pollen on 
the reported presence or absence of allergy symptoms in Croatian children keeping a daily symptom 
diary and used these to develop dose-response curves.  We have demonstrated lag effects on 
symptoms, the pollen thresholds needed for symptoms to occur and highlighted how different 
symptoms respond to different pollen exposure levels.  Under future conditions of climate change, it 
is predicted that the distribution of ragweed will expand throughout Europe (Storkey et al., 2014) 
and the numbers of people sensitised to this allergen could more than double (Lake et al., 2017).  
Thus, the numbers of people suffering allergy symptoms due to ragweed exposure is likely to 
increase.  The findings from this study could be used to address this challenge by combining the 
dose-response curves developed with predictive pollen modelling (such as in Voukantsis et al. 
(2010)) to develop early warning systems and provide allergy sufferers with adequate information to 
allow them to better pre-empt and manage allergy symptoms.  
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Preparedness and Response at King’s College London.   
 
Tables 
Table 1: Summary characteristics of children  
 
Number of children (%) 
(n=85) 
Age at entry 
into study 
4 9 (11%) 
5 6 (7%) 
6 7 (8%) 
7 16 (19%) 
8 16 (19%) 
9 21 (25%) 
10 10 (12%) 
Gender 
Male 53 (62%) 
Female 32 (38%) 
Pollen seasona 
2012 29 (34%) 
2013 49 (57%) 
2014 24 (28%) 
Home region 
Zagreb 54 (64%) 
Slavonia 25 (29%) 
Dalmatia 6 (7%) 
Reported 
symptomsb 
Eye 56 (66%) 
Nasal 75 (88%) 
Lung 41 (48%) 
a17 children completed the diary in more than one pollen season 
b64 children reported more than one symptom type 
  
Table 2: Model showing associations with the reported presence or absence of eye symptoms  
  
 
Odds Ratio [CI] p 
Age 
4–7 Ref  
8 0.26 [0.05, 1.31] 0.096 
9 0.16 [0.02, 1.07] 0.054 
10–12 0.07 [0.01, 0.67] 0.019 
Gender  
Male Ref  
Female 0.68 [0.02, 21.56] 0.825 
Location 
At home Ref  
Away from home 0.54 [0.30, 0.97] 0.036 
Reported eye symptoms on previous day 45.21 [32.56, 62.78] <0.001 
Self (or parental)-reported allergic rhinitis symptoms 
in child 
1.80 [0.03, 103.28] 0.771 
Self (or parental)-reported asthma symptoms in child 0.62 [0.01, 28.24] 0.803 
Taking nasal spray or nose drops on day of symptoms 18.91 [9.48, 37.69] <0.001 
Taking nasal spray or nose drops on previous day 0.31 [0.16, 0.61] 0.001 
Taking anti-allergy tablets on day of symptoms 0.89 [0.04, 22.21] 0.940 
Time spent being active outside 0.85 [0.75, 0.96] 0.009 
Monthly 
Household 
Income 
<€660 Ref  
€660-€1320 0.30 [0.01, 12.00] 0.517 
>€1320 0.29 [0.01, 15.18] 0.535 
Year 
2012 Ref  
2013 4.48 [2.21, 9.07] <0.001 
2014 0.90 [0.31, 2.63] 0.842 
Mean daily temperature (oC)  1.09 [1.03, 1.16] 0.002 
Daily rainfall (mm) 0.99 [0.97, 1.02] 0.586 
Mean SO2 (µg/m3) over previous 4 days 0.99 [0.94, 1.03] 0.550 
Mean PM10 (µg/m3) over previous 4 days 1.00 [0.98, 1.03] 0.993 
Mean O3 (µg/m3) over previous 4 days 1.01 [1.00, 1.03] 0.098 
Italics indicate significant findings 
Deviance explained 66.7% ; AIC = 1349.82 ; Dispersion parameter = 0.611 
 
  
Table 3: Model showing associations with the reported presence or absence of nasal symptoms  
  
 
Odds Ratio [95% CI] p 
Age 
4–7 Ref  
8 0.60 [0.16, 2.24] 0.440 
9 0.91 [0.19, 4.28] 0.899 
10–12 0.79 [0.13, 4.64] 0.787 
Gender 
Male Ref  
Female 0.61 [0.09, 4.01] 0.602 
Location 
At home Ref  
Away from home 0.39 [0.22, 0.69] 0.001 
Reported nasal symptoms on previous day 71.45 [50.41, 101.26] <0.001 
Self (or parental)-reported allergic rhinitis symptoms 
in child 
1.79 [0.21, 14.98] 0.586 
Self (or parental)-reported asthma symptoms in child 0.73 [0.09, 6.06] 0.767 
Taking nasal spray or nose drops on day of symptoms 10.07 [5.18, 19.55] <0.001 
Monthly 
Household Income 
<€660 Ref  
€660-€1320 1.08 [0.13, 8.81] 0.942 
>€1320 1.25 [0.13, 12.07] 0.843 
Child has been treated by doctor for worms 1.16 [0.03, 42.48] 0.934 
Year 
2012 Ref  
2013 2.87 [1.37, 6.02] 0.004 
2014 0.69 [0.26, 1.79] 0.432 
Mean daily temperature (oC)  1.07 [1.01, 1.14] 0.012 
Daily rainfall (mm) 0.98 [0.96, 1.00] 0.037 
Mean SO2 (µg/m3) over previous 12 days 0.99 [0.92, 1.08] 0.870 
Mean PM10 (µg/m3) over previous 12 days 0.99 [0.96, 1.03] 0.775 
Mean O3 (µg/m3) over previous 12 days 0.99 [0.98, 1.01] 0.541 
Italics indicate significant findings 
Deviance explained 73.1%; AIC = 1230.319 ; Dispersion parameter = 1.020 
  
Table 4: Model showing associations with the reported presence or absence of lung symptoms 
  
 
Odds Ratio [95% CI] p 
Age 
4–7  Ref  
8 0.39 [0.03, 4.54] 0.443 
9 1.55 [0.11, 21.81] 0.741 
10–12  4.06 [0.20, 83.29] 0.354 
Gender  
Male Ref  
Female 1.00 [0.04, 27.43] 0.999 
Location 
At home Ref  
Away from home 0.83 [0.32, 2.10] 0.683 
Reported lung symptoms on previous day 35.40 [21.42, 58.48] <0.001 
Self (or parental)-reported allergic rhinitis symptoms in child 0.84 [0.01, 61.43] 0.936 
Self (or parental)-reported asthma symptoms in child 12.91 [0.28, 595.87] 0.182 
Taking asthma medication on day of symptoms 3.57 [1.86, 6.88] <0.001 
Time spent being active  0.78 [0.64,0.96] 0.014 
Monthly 
Household 
Income 
<€660 Ref  
€660-€1320  0.14 [0.00, 6.63] 0.311 
>€1320 0.23 [0.00, 14.33] 0.473 
Child has an asthmatic parent 8.03 [0.14, 454.72] 0.302 
Type of area 
child lives in  
Rural area Ref  
Urban area 24.67 [0.41, 1468.70] 0.117 
Year 
2012 Ref  
2013 0.45 [0.15, 1.32] 0.138 
2014 0.16 [0.03, 0.88] 0.032 
Mean daily temperature (oC) 1.01 [0.94, 1.08] 0.837 
Daily rainfall (mm) 0.97 [0.94, 1.01] 0.101 
Mean SO2 (µg/m3) over previous 19 days 0.99 [0.85, 1.15] 0.911 
Mean PM10 (µg/m3) over previous 19 days 1.01 [0.94, 1.09] 0.737 
Mean O3 (µg/m3) over previous 19 days 1.00 [0.98, 1.03] 0.762 
Italics indicate significant findings 
Deviance explained 77% ; AIC = 636.663; Dispersion parameter = 0.4246 
 
 
  
Figures 
  
Figure 1: Relationship between total daily pollen grains/m3 and percentage of days when children 
reported symptoms.  
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Figure 2:  Relationship between mean daily pollen concentration lagged 0 to 3 days (Pollen03) 
and reported eye symptoms from a Generalised Additive Mixed Model.  The X axis represents 
increasing pollen concentration.  The rug (lines) at the bottom indicates the density of 
observations at each level of pollen.  The Y axis represents the probability of reported eye 
symptoms.  The smooth line indicates the maximum likelihood estimates for the probability of 
symptoms, and the dashed lines represent the 95% confidence intervals.  The dotted lines 
indicate the threshold at which 50% of children reported symptoms. 
 
Figure 3:  Relationship between mean daily pollen concentration lagged 0 to 11 days (Pollen011) 
and reported nasal symptoms from a Generalised Additive Mixed Model.  The X axis represents 
increasing pollen concentration.  The rug (lines) at the bottom indicates the density of 
observations at each level of pollen.  The Y axis represents the probability of reported eye 
symptoms.  The smooth line indicates the maximum likelihood estimates for the probability of 
symptoms, and the dashed lines represent the 95% confidence intervals.  The dotted lines 
indicate the threshold at which 50% of children reported symptoms. 
 
Figure 4:  Relationship between mean daily pollen concentration lagged 0 to 18 days (Pollen018) 
and reported lung symptoms from a Generalised Additive Mixed Model.  The X axis represents 
increasing pollen concentration.  The rug (lines) at the bottom indicates the density of 
observations at each level of pollen.  The Y axis represents the probability of reported eye 
symptoms.  The smooth line indicates the maximum likelihood estimates for the probability of 
symptoms, and the dashed lines represent the 95% confidence intervals.  The dotted lines 
indicate the threshold at which 50% of children reported symptoms. 
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Table S1: Significance of daily pollen lags for eye, nose and lung symptoms 
 p 
Day Eye symptoms Nose symptoms Lung symptoms 
0 <0.001 <0.001 <0.001 
1 <0.001 <0.001 <0.001 
2 <0.001 0.001 <0.001 
3 <0.001 <0.001 <0.001 
4 0.010 <0.001 0.002 
5 0.016 0.003 <0.001 
6 0.028 <0.001 <0.001 
7 0.024 <0.001 <0.001 
8 0.114 0.001 <0.001 
9 0.035 <0.001 <0.001 
10 0.074 0.001 <0.001 
11 0.009 0.001 <0.001 
12 0.210 0.035 <0.001 
13 0.847 0.081 <0.001 
14 0.761 0.117 0.001 
15 0.807 0.006 0.001 
16 0.737 0.043 <0.001 
17 0.555 0.028 <0.001 
18 0.370 0.049 0.007 
19 0.076 0.498 0.019 
20 0.223 0.961 0.049 
 
  
Table S2: Explanatory variables used in analysis 
 Variable  
Time series Mean Pollen concentration lagged over days zero to three (Pollen 0:3) 
 Mean Pollen concentration lagged over days zero to eleven (Pollen 0:11) 
 Mean Pollen concentration lagged over days zero to eighteen (Pollen 0:18) 
 Day of the week 
 Weekend 
 Year (2012; 2013; 2014) 
 Season (Early or late pollen season) 
 Location of child in Day (At home or Away from home) 
 Reported eye symptoms on previous day 
 Reported nasal symptoms on previous day 
 Reported lung symptoms on previous day 
 Self (or parental)-reported allergic rhinitis symptoms in child 
 Self (or parental)-reported allergic asthma symptoms in child 
 Taking nasal spray or nose drops on day of symptoms 
 Taking nasal spray or nose drops on previous day 
 Taking anti-allergy tablets on day of symptoms 
 Taking anti-allergy tablets on previous day 
 Taking asthma medication on day of symptoms 
 Taking asthma medication on previous day 
 Time spent being active 
 Time spent being active outside 
 Mean daily temperature (oC)  
 Maximum daily temperature (oC) 
 Minimum daily temperature (oC) 
 Daily rainfall (mm) 
 Mean SO2 (µg/m3) over previous 4/12/19  days 
 Mean PM10 (µg/m3) over previous 4/12/19  days 
 Mean NO2 (µg/m3) over previous 4/12/19  days 
 Mean O3 (µg/m3) over previous 4/12/19 days 
Individual  Age at entry into study 
 Gender 
 Sensitisation to other allergens 
 Atopic parent 
 Child order 
 Use of antibiotics in first year of life 
 Maternal smoking in pregnancy 
 Child has been treated by doctor for worms 
 Respiratory infection in childhood 
 Does child sleep on feather pillow 
 Asthmatic parent 
 Has atopic family member 
 Number of bedrooms in home 
 Number of adults in household 
 Education of father (Higher than secondary level; High school diploma or lower) 
 Education of Mother (Higher than secondary level; High school diploma or lower) 
 Monthly Household Income (<€660; €660-€1320; >€1320) 
 Lives in Urban or Rural area 
 
 
  
Table S3: Change in AIC over each model addition 
Additions to model AIC 
  
Eye model 
Core model 2358.19 
Monthly household Income 1955.25 
Mean O3 (µg/m3) over previous 4 days 1750.75 
Location (at home or away from home) 1640.88 
Taking anti-allergy tablets on day of symptoms 1564.37 
Taking nasal spray or nose drops on day of symptoms 1502.76 
Self (or parental)-reported allergic rhinitis symptoms in child 1446.85 
Self (or parental)-reported asthma symptoms in child 1399.50 
Mean PM10 (µg/m3) over previous 4 days 1373.26 
Mean SO2 (µg/m3) over previous 4 days 1363.46 
Taking nasal spray or nose drops on previous day 1354.90 
Time spent being active outside 1349.82 
  
Nose model 
Core model 2369.80 
Monthly household Income 1815.58 
Mean O3 (µg/m3) over previous 12 days 1536.82 
Location (at home or away from home) 1447.77 
Taking nasal spray or nose drops on day of symptoms 1385.68 
Child has been treated by doctor for worms 1330.46 
Mean PM10 (µg/m3) over previous 12 days 1283.12 
Self (or parental)-reported allergic rhinitis symptoms in child 1261.51 
Mean SO2 (µg/m3) over previous 12 days 1241.56 
Self (or parental)-reported asthma symptoms in child 1230.32 
  
Lung model 
Core model 1381.89 
Mean O3 (µg/m3) over previous 19 days 1063.19 
Monthly household Income 855.82 
Mean PM10 (µg/m3) over previous 19 days 772.61 
Location (at home or away from home) 724.38 
Mean SO2 (µg/m3) over previous 19 days 697.24 
Child has asthmatic parent 673.04 
Taking asthma medication on day of symptoms 654.89 
Self (or parental)-reported allergic rhinitis symptoms in child 646.52 
Time spent being active 642.51 
Self (or parental)-reported asthma symptoms in child 639.52 
Type of area child lives in (Rural or Urban) 636.66 
Core model: Child (random effect), Area (random effect), average pollen (over 4/12/19 days), 
reported eye/nose/lung symptoms on previous day, gender, age, year, mean daily temperature (oC), 
daily rainfall (mm)  
 
 
